Skip to content

Compare the vasodilation properties of cyclopofol and propofol using the perfusion index

Compare the vasodilation properties of cyclopofol and propofol using the perfusion index

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094336
Enrollment
Unknown
Registered
2024-12-20
Start date
2024-12-26
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effects of anesthetic drugs on the body

Interventions

Cyclopofol group:Intravenous injection of cyclosporine 0.4mg/kg
Propofol group:intravenous injection of propofol 2mg/kg

Sponsors

The Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1)Observation age 22~45 years old; 2)female; 3) ASAI~II; 4) height 150~170cm; 5)body mass index 18~28kg/m²; 6)planned to perform surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1) Recent use of any medications that affect vasotonia (e.g., vasoactive medications, calcium channel blockers, or angiotensin-converting enzyme inhibitors); 2) cardiovascular or peripheral vascular disease (e.g., Raynaud syndrome); 3) medications that may affect the sympathetic or parasympathetic nerves (e.g., anticholinergics or ß-blockers); 4) diabetes mellitus, neurological or psychiatric disorders, history of substance abuse, history of anxiety or depression; 5) monitoring fingers for nail polish; 6) anemia, electrolyte acid-base imbalance; 7) abnormal body temperature or hand temperature.

Design outcomes

Primary

MeasureTime frame
Perfusion index (PI);

Secondary

MeasureTime frame
Mean arterial pressure;pulse;

Countries

China

Contacts

Public ContactJi Leting

The Third Affiliated Hospital of Zhengzhou University

jlt0001@126.com+86 185 3800 6729

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026